基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Hoerter Steven L., 首席执行官. Insider active across 2 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 8 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €783k. Activity tracked since 21 March 2022. The latest transaction was disclosed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Hoerter Steven L. is Directeur Général. Across the 8 filings recorded, the most recent filings covered the period from 2022-03-23 to 2026-08-04, with EUR 226490 of buys and EUR 556944 of sells in the sampled recent filings, mainly in Deciphera Pharmaceuticals, Inc. and MBX Biosciences, Inc. The modal transaction nature is Attribution.